Achievements and obstacles of remyelinating therapies in multiple sclerosis
Crossref DOI link: https://doi.org/10.1038/nrneurol.2017.139
Published Online: 2017-11-17
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stangel, Martin
Kuhlmann, Tanja
Matthews, Paul M.
Kilpatrick, Trevor J.
Text and Data Mining valid from 2017-11-17
Article History
First Online: 17 November 2017
Competing interests
: The authors declare no competing financial interests.